Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qinming Medical is a Chinese cardiovascular medical device company focused on implantable cardiac rhythm management products, especially pacemakers and pacing leads. The business is best known for developing domestically produced implantable pacemakers in China, including the Qinming 8631 series and associated lead systems. Historically known as Shaanxi Qinming Medical Instruments, the company was progressively acquired by Lepu Medical and now operates as a Lepu subsidiary/business unit for pacemaker development, manufacturing, and commercialization. Its products are marketed for bradyarrhythmia and related pacing indications, and the company appears to be commercial-stage rather than a therapeutics developer. Qinming is therefore healthcare-related, but it is a device manufacturer rather than a biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qinming Medical.